Universität zu Köln

Baumann, Dr. S., Becher, T., Giannakopoulos, K., Jabbour, C., Fastner, C., El-Battrawy, I., Ansari, U., Lossnitzer, D., Behnes, M., Alonso, A., Kirschning, T., Dissmann, R., Kueck, O., Stern, D., Michels, G., Borggrefe, M. and Akin, I. (2018). Bedside implantation of a new temporary vena cava inferior filter. German results from the European ANGEL registry. Med. Klin.-Intensivmed Notfallmed., 113 (3). S. 184 - 192. NEW YORK: SPRINGER. ISSN 2193-6218

Full text not available from this repository.

Abstract

Background. Pulmonary embolism(PE) is a frequently occurring complication in critically ill patients, and the simultaneous occurrence of PE and life-threatening bleeding is a therapeutic dilemma. Inferior vena cava filters (IVCF) may represent an important therapeutic alternative in these cases. The Angel (R) catheter (Bio2 Medical Inc., San Antonio, TX, USA) is a novel IVCF that provides temporary protection from PE and is implanted at bedside without fluoroscopy. Material and methods. The European Angel (R) Catheter Registry is an observational, multicenter study. In our German substudy, we investigated patients from three German hospitals and four intensive care units, who underwent Angel (R) catheter implantation between February 2016 and December 2016. Results. A total of 23 critically ill patients (68 +/- 9 years, 43% male) were included. The main indication for implantation was a high risk for or an established PE, combined with contraindications for prophylactic or therapeutic anticoagulation due to either an increased risk of bleeding (81%) or active bleeding (13%). The Angel (R) catheter was successfully inserted in all patients at bedside. No PE occurred in patients with an indwelling Angel (R) catheter. Clots with a diameter larger the 20 mm, indicating clot migration, were detected in 5% of the patients by cavography before filter retrieval. Filter retrieval was uneventful in all of our cases, while filter dislocation occurred in 3% of the patients. Conclusion. The German data from the multicenter European Angel (R) Catheter Registry show that the Angel (R) catheter is a safe and effective approach for critically ill patients with a high risk for the development of PE or an established PE, when an anticoagulation therapy is contraindicated.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Baumann, Dr. S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Becher, T. UNSPECIFIED UNSPECIFIED UNSPECIFIED Giannakopoulos, K. UNSPECIFIED UNSPECIFIED UNSPECIFIED Jabbour, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Fastner, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED El-Battrawy, I. UNSPECIFIED UNSPECIFIED UNSPECIFIED Ansari, U. UNSPECIFIED UNSPECIFIED UNSPECIFIED Lossnitzer, D. UNSPECIFIED UNSPECIFIED UNSPECIFIED Behnes, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Alonso, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Kirschning, T. UNSPECIFIED UNSPECIFIED UNSPECIFIED Dissmann, R. UNSPECIFIED UNSPECIFIED UNSPECIFIED Kueck, O. UNSPECIFIED UNSPECIFIED UNSPECIFIED Stern, D. UNSPECIFIED UNSPECIFIED UNSPECIFIED Michels, G. UNSPECIFIED UNSPECIFIED UNSPECIFIED Borggrefe, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Akin, I. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-191468
DOI:	10.1007/s00063-017-0294-9
Journal or Publication Title:	Med. Klin.-Intensivmed Notfallmed.
Volume:	113
Number:	3
Page Range:	S. 184 - 192
Date:	2018
Publisher:	SPRINGER
Place of Publication:	NEW YORK
ISSN:	2193-6218
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language DEEP-VEIN THROMBOSIS; CRITICALLY-ILL PATIENTS; PULMONARY-EMBOLISM; VENOUS THROMBOEMBOLISM; MEDICAL PATIENTS; PREVENTION; MANAGEMENT; SURVIVAL; SAFETY; TRIAL Multiple languages Medicine, General & Internal Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/19146